We determined whether the effect of alcohol (ALC) to suppress LH secretion in immature female monkeys is due to a hypothalamic or pituitary site of action. Beginning at 20 months of age, four monkeys received a single intragastric dose of ALC (2.4 g/kg), and four monkeys received an equal volume of a saline/sucrose solution daily until they were 36 months old. For the hypothalamic response test, two basal samples (3.5 ml) were collected at 15-min intervals via the saphenous vein, and then N-methyl-D-L-aspartic acid (NMA; 20 mg/kg) was given iv and four more blood samples collected. Three weeks later, this protocol was repeated except LH-releasing hormone (LHRH) (5 g/kg) was used to test pituitary responsiveness. NMA or LHRH was administered 3 h after the ALC. After the pituitary challenge, each monkey was ovariectomized and 6 wk later, implanted with an indwelling subclavian vein catheter. Blood samples were drawn every 10 min for 8 h to assess effects of ALC on post-ovariectomy LH levels and the profile of LH pulsatile secretion. The hypothalamic challenge showed NMA stimulated LH release in control monkeys, an action that was blocked by ALC. The pituitary challenge revealed that LHRH stimulated LH release equally well in control and ALC-treated monkeys. A post-ovariectomy rise in LH was observed in both groups, but levels were 45% lower in ALC-treated monkeys.
This reduction was attributed to an ALC-induced suppression of both baseline and amplitude of pulses. Results demonstrate that the ALC-induced suppression of LH in immature female rhesus monkeys is due to an inhibitory action of the drug at the hypothalamic level. (Endocrinology 145: 4558 -4564, 2004)I N RECENT YEARS, there has been an increase in alcohol (ALC) use and abuse during adolescence, especially by females (1). The adolescent period is a potentially vulnerable time for developing individuals who may be more sensitive to the drug and less tolerant to its detrimental effects than adults. This concept has been supported by work using the rat as an animal model (2, 3). The possibility that ALC could alter neuroendocrine development has been suspected for years because a history of any drug ingestion is routinely conducted to identify potential causes of altered endocrine function or pubertal development. Any detrimental effect of ALC on puberty-related hormones at this critical time of growth and development could elevate the risk for developmental deficits.Research with experimental animals and case reports from humans further suggest that determining the effects of ALC on endocrine development warrants serious consideration. Studies using rats have shown that ALC suppresses the levels of LH and estradiol (E 2 ) and causes delayed female puberty (4 -6). Even though case studies involving ALC use and abuse by adolescent and teenage humans are limited in number and scope, they have suggested that the drug can disrupt endocrine function, stature, and weight distribution in young people (7-9), as well as place them at risk for nutritional deficiencies ...